{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:57:08Z","timestamp":1793213828011,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ijpharm.2018.07.062","type":"journal-article","created":{"date-parts":[[2018,7,29]],"date-time":"2018-07-29T11:49:39Z","timestamp":1532864979000},"page":"363-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Printing T3 and T4 oral drug combinations as a novel strategy for hypothyroidism"],"prefix":"10.1016","volume":"549","author":[{"given":"Mustafa","family":"Alomari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswara R.","family":"Vuddanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Trenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius C.","family":"Dodoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-5410","authenticated-orcid":false,"given":"Sitaram","family":"Velaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul W.","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1000-3208","authenticated-orcid":false,"given":"Simon","family":"Gaisford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.07.062_b0005","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s11095-016-1933-1","article-title":"Emergence of 3D printed dosage forms: opportunities and challenges","volume":"33","author":"Alhnan","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijpharm.2014.12.006","article-title":"Personalised dosing: printing a dose of one\u2019s own medicine","volume":"494","author":"Alomari","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0015","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1210\/jc.2004-2111","article-title":"Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial","volume":"90","author":"Appelhof","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0020","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijpharm.2018.07.024","article-title":"3D printed medicines: a new branch of digital healthcare","volume":"548","author":"Awad","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2018.05.025","article-title":"Reshaping drug development using 3D printing","author":"Awad","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2018.07.062_b0030","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/pharmaceutics5040621","article-title":"Oral Liquid formulation of levothyroxine is stable in breakfast beverages and may improve thyroid patient compliance","volume":"5","author":"Bernareggi","year":"2013","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2018.07.062_b0035","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1210\/jc.2011-3399","article-title":"Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism?","volume":"97","author":"Biondi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0040","unstructured":"BNF, 2017. Levothyroxine Sodium."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0045","unstructured":"BNF, 2018. Liothyronine."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0050","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1007\/s11095-011-0450-5","article-title":"Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing","volume":"28","author":"Buanz","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199902113400603","article-title":"Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism","volume":"340","author":"Bunevi\u010dius","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0060","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1210\/jc.2011-1329","article-title":"Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine","volume":"96","author":"Celi","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jpba.2010.08.025","article-title":"Development and application of a validated HPLC method for the analysis of dissolution samples of levothyroxine sodium drug products","volume":"54","author":"Collier","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0070","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijpharm.2015.03.017","article-title":"Inkjet printing for pharmaceutics \u2013 a review of research and manufacturing","volume":"494","author":"Daly","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0075","unstructured":"DrugBank, 2005a. Levothyroxine."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0080","unstructured":"DrugBank, 2005b. Liothyronine."},{"key":"10.1016\/j.ijpharm.2018.07.062_b9015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2017.11.052","article-title":"QR encoded smart oral dosage forms by inkjet printing","volume":"536","author":"Edinger","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0085","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-142-6-200503150-00007","article-title":"Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone","volume":"142","author":"Escobar-Morreale","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0090","series-title":"Guidance for Industry - Orally Disintegrating Tablets","author":"FDA","year":"2008"},{"key":"10.1016\/j.ijpharm.2018.07.062_b0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1211\/jpp.62.04.0018","article-title":"Comparative investigations on different polymers for the preparation of fast-dissolving oral films","volume":"62","author":"Garsuch","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.07.062_b9020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijpharm.2013.06.003","article-title":"Behavior of printable formulations of loperamide and caffeine on different substrates\u2014Effect of print density in inkjet printing","volume":"453","author":"Genina","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b9025","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ejpb.2013.03.017","article-title":"Evaluation of different substrates for inkjet printing of rasagiline mesylate","volume":"85","author":"Genina","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0100","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1021\/acs.molpharmaceut.5b00510","article-title":"3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics","volume":"12","author":"Goyanes","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jconrel.2015.09.028","article-title":"3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles","volume":"217","author":"Khaled","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.07.062_b0110","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ijpharm.2015.07.067","article-title":"3D printing of tablets containing multiple drugs with defined release profiles","volume":"494","author":"Khaled","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1891\/0730-0832.19.8.11","article-title":"The thyroid gland: physiology and pathophysiology","volume":"19","author":"Kirsten","year":"2000","journal-title":"Neonatal Network"},{"key":"10.1016\/j.ijpharm.2018.07.062_b0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejps.2018.01.036","article-title":"Inkjet printing of paracetamol and indomethacin using electromagnetic technology: rheological compatibility and polymorphic selectivity","volume":"115","author":"Kollamaram","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2018.04.014","article-title":"Tailoring supersaturation from amorphous solid dispersions","volume":"279","author":"Li","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.07.062_b0135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1208\/s12249-011-9729-4","article-title":"Characterization of oral disintegrating film containing donepezil for Alzheimer disease","volume":"13","author":"Liew","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2018.07.062_b0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2017.10.008","article-title":"3D printed multi-compartment capsular devices for two-pulse oral drug delivery","volume":"268","author":"Maroni","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.07.062_b0145","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1002\/jps.21189","article-title":"Thermal inkjet application in the preparation of oral dosage forms: dispensing of prednisolone solutions and polymorphic characterization by solid-state spectroscopic techniques","volume":"97","author":"Mel\u00e9ndez","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.07.062_b9035","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-018-1105-1","article-title":"The effect of inkjet printing over polymeric films as potential buccal biologics delivery systems","author":"Montenegro-Nicolini","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2018.07.062_b0150","doi-asserted-by":"crossref","first-page":"120","DOI":"10.14310\/horm.2002.11120","article-title":"The serum triiodothyronine to thyroxine (T3\/T4) ratio in various thyroid disorders and after Levothyroxine replacement therapy","volume":"3","author":"Mortoglou","year":"2004","journal-title":"Hormones"},{"key":"10.1016\/j.ijpharm.2018.07.062_b9030","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijpharm.2015.10.054","article-title":"Printing medicines as orodispersible dosage forms: Effect of substrate on the printed micro-structure","volume":"509","author":"Planchette","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0155","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ijpharm.2015.02.032","article-title":"Perspective: concepts of printing technologies for oral film formulations","volume":"494","author":"Preis","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0160","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1081\/JLC-100101481","article-title":"Rapid HPLC analysis of thyroid gland hormones tri-iodothyronine (T3) and thyroxine (T4) in human biological fluids after SPE","volume":"23","author":"Samanidou","year":"2000","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0165","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1002\/jps.22526","article-title":"Inkjet printing of drug substances and use of porous substrates-towards individualized dosing","volume":"100","author":"Sandler","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0170","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1210\/jc.2004-1672","article-title":"Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial","volume":"90","author":"Saravanan","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijpharm.2018.07.062_b9010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijpharm.2017.03.018","article-title":"Orodispersible films: towards drug delivery in special populations","volume":"523","author":"Scarpa","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0175","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2011.07.033","article-title":"Inkjet printing as a novel medicine formulation technique","volume":"156","author":"Scoutaris","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.07.062_b0180","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1208\/s12249-010-9515-8","article-title":"Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium","volume":"11","author":"Shah","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2018.07.062_b9040","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijpharm.2018.04.064","article-title":"Continuous inkjet printing of enalapril maleate onto orodispersible film formulations","volume":"546","author":"Thabet","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0185","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.tips.2018.02.006","article-title":"3D printing pharmaceuticals: drug development to frontline care","volume":"39","author":"Trenfield","year":"2018","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.07.062_b9005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2018.08.002","article-title":"3D printed drug products: non-destructive dose verification using a rapid point-and-shoot approach","author":"Trenfield","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0190","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a801","article-title":"Management of hypothyroidism in adults","volume":"337","author":"Vaidya","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ijpharm.2018.07.062_b0195","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijpharm.2017.04.014","article-title":"Application of a handheld NIR spectrometer in prediction of drug content in inkjet printed orodispersible formulations containing prednisolone and levothyroxine","volume":"524","author":"Vakili","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0200","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ijpharm.2017.04.036","article-title":"Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration","volume":"531","author":"Varan","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0205","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejps.2018.02.002","article-title":"Personalisation of warfarin therapy using thermal ink-jet printing","volume":"117","author":"Vuddanda","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0210","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1471-4892(02)00209-6","article-title":"Dissatisfaction with thyroxine therapy \u2014 could the patients be right?","volume":"2","author":"Walsh","year":"2002","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0215","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.med.0000432611.03732.49","article-title":"Combination L-T3 and L-T4 therapy for hypothyroidism","volume":"20","author":"Wartofsky","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0220","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ijpharm.2017.08.036","article-title":"Handheld colorimeter as quality control tool for inkjet printed flexible levothyroxine doses for pediatric use","volume":"536","author":"Wickstr\u00f6m","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.07.062_b0225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1208\/s12249-016-0620-1","article-title":"Colorimetry as quality control tool for individual inkjet-printed pediatric formulations","volume":"18","author":"Wickstr\u00f6m","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2018.07.062_b0230","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1530\/EJE-09-0879","article-title":"Do we need still more trials on T4 and T3 combination therapy in hypothyroidism?","volume":"161","author":"Wiersinga","year":"2009","journal-title":"Eur. J. Endocrinol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318305465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318305465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T19:04:54Z","timestamp":1717268694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318305465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":53,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0378517318305465"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.07.062","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Printing T3 and T4 oral drug combinations as a novel strategy for hypothyroidism","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.07.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}